Overall, our results show that progerin expression in ECs leads to defects in nucleocytoskeletal coupling, in flow stress response, and in MRTFA/eNOS signaling, which in turn induce profibrotic changes, cardiovascular stiffening, and cardiac hypertrophy. This evidence concerns the gene NOS3 and cardiac hypertrophy.